Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has published the medical cannabis import figures for Q3, showing that the country’s medical cannabis market is still growing rapidly.
Since April 01, 2024, and the implementation of CanG and MedCanG, cannabis has no longer been considered a ‘narcotic’ substance in Germany, making the process of both securing and prescribing medical cannabis significantly easier.
In the third quarter, medical cannabis imports grew by over 70% from the previous period, the first full three months in which Germany’s sweeping cannabis reforms were put into place.
While it’s unclear how much of these imports actually made it to pharmacies, as these figures are no longer tracked by BfArM, industry insiders suggest these levels have also risen since April.
The figures
Overall imports of cannabis for medical and medical-scientific purposes in the form of dried flowers (in kg ) grew to 20.1 tonnes in Q3, a 71.9% rise on Q2 2024, and a 140% increase on the same period a year earlier.
This means total imports now stand at 39.8 tonnes for the first nine months of the year, a 21.4% increase compared to the whole year of 2023.Canada remains the largest exporter to Germany by some margin and saw exports rise 72% (8098 kg) in the third quarter alone.
